Publication:

lncRNA Chronos is an aging-induced inhibitor of muscle hypertrophy

Loading...
Thumbnail Image

Open/View Files

Date

2017

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Rockefeller University Press
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Neppl, Ronald L, Chia-Ling Wu, and Kenneth Walsh. 2017. “lncRNA Chronos is an aging-induced inhibitor of muscle hypertrophy.” The Journal of Cell Biology 216 (11): 3497-3507. doi:10.1083/jcb.201612100. http://dx.doi.org/10.1083/jcb.201612100.

Abstract

Skeletal muscle exhibits remarkable plasticity in its ability to modulate its mass in response to the physiologic changes associated with functional use, systemic disease, and aging. Although a gradual loss of muscle mass normally occurs with advancing age, its increasingly rapid progression results in sarcopenia in a subset of individuals. The identities of muscle-enriched, long noncoding RNAs that regulate this process are unknown. Here, we identify a long noncoding RNA, named Chronos, whose expression in muscle is positively regulated with advancing age and negatively regulated during Akt1-mediated growth. Inhibition of Chronos induces myofiber hypertrophy both in vitro and in vivo, in part, through the epigenetic modulation of Bmp7 signaling.

Description

Research Data

Keywords

Report

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories